Decision-Making with New Approach Methodologies: Time to Replace Default Uncertainty Factors with Data.
作者信息
Rusyn Ivan, Chiu Weihsueh A
机构信息
Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas 77843, USA.
出版信息
Toxicol Sci. 2022 Aug 25;189(1):148-149. doi: 10.1093/toxsci/kfac033.
Abstract
摘要
相似文献
1
Decision-Making with New Approach Methodologies: Time to Replace Default Uncertainty Factors with Data.采用新方法学进行决策：是时候用数据取代默认不确定性因素了。
Toxicol Sci. 2022 Aug 25;189(1):148-149. doi: 10.1093/toxsci/kfac033.
2
Response to Decision-Making with New Approach Methodologies: Time to Replace Default Uncertainty Factors with Data.
Toxicol Sci. 2022 Aug 25;189(1):150-151. doi: 10.1093/toxsci/kfac034.
3
Guided adaptive optimal decision making approach for uncertainty based watershed scale load reduction.基于不确定性的流域尺度负荷削减的引导自适应最优决策方法。
Water Res. 2011 Oct 15;45(16):4885-95. doi: 10.1016/j.watres.2011.06.038. Epub 2011 Jul 3.
4
Coverage with evidence development: the Ontario experience.循证医保覆盖：安大略省的经验。
Int J Technol Assess Health Care. 2011 Apr;27(2):159-68. doi: 10.1017/S0266462311000018.
5
A tiered, Bayesian approach to estimating of population variability for regulatory decision-making.一种用于监管决策的分层贝叶斯方法来估计群体变异性。
ALTEX. 2017;34(3):377-388. doi: 10.14573/altex.1608251. Epub 2016 Dec 13.
6
Managing scientific uncertainty in medical decision making: the case of the advisory committee on immunization practices.应对医疗决策中的科学不确定性：以免疫实践咨询委员会为例。
J Med Philos. 2012 Feb;37(1):6-27. doi: 10.1093/jmp/jhr056. Epub 2011 Dec 23.
7
Decision making under uncertainty in a quasi realistic binary decision task - An fMRI study.准现实二元决策任务中不确定性下的决策制定——一项功能磁共振成像研究
Brain Cogn. 2020 Apr;140:105549. doi: 10.1016/j.bandc.2020.105549. Epub 2020 Feb 20.
8
How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making.患者如何看待肺癌筛查。医学决策不确定性的作用。
Ann Am Thorac Soc. 2016 Nov;13(11):1969-1976. doi: 10.1513/AnnalsATS.201604-290OC.
9
Making policy decisions under plural uncertainty: responding to the COVID-19 pandemic.在多重不确定性下制定政策决策：应对 COVID-19 大流行。
Hist Philos Life Sci. 2021 Apr 14;43(2):56. doi: 10.1007/s40656-021-00411-9.
10
Factors associated with confidence in decision making and satisfaction with risk communication among patients with atrial fibrillation.与房颤患者决策信心及风险沟通满意度相关的因素。
Eur J Cardiovasc Nurs. 2018 Jun;17(5):446-455. doi: 10.1177/1474515117741891. Epub 2017 Nov 14.
引用本文的文献
1
A workflow for human health hazard evaluation using transcriptomic data and Key Characteristics-based gene sets.一种使用转录组数据和基于关键特征的基因集进行人类健康危害评估的工作流程。
Toxicol Sci. 2025 Jun 1;205(2):310-325. doi: 10.1093/toxsci/kfaf036.
2
Incorporating new approach methods (NAMs) data in dose-response assessments: The future is now!将新方法（NAMs）数据纳入剂量反应评估：未来已来！
J Toxicol Environ Health B Crit Rev. 2025 Jan 2;28(1):28-62. doi: 10.1080/10937404.2024.2412571. Epub 2024 Oct 10.
3
Characterizing PFAS hazards and risks: a human population-based in vitro cardiotoxicity assessment strategy.描述 PFAS 危害和风险：基于人群的体外心脏毒性评估策略。
Hum Genomics. 2024 Sep 2;18(1):92. doi: 10.1186/s40246-024-00665-x.
4
Reducing uncertainty in dose-response assessments by incorporating Bayesian benchmark dose modeling and in vitro data on population variability.通过纳入贝叶斯基准剂量模型和关于群体变异性的体外数据来降低剂量反应评估中的不确定性。
Risk Anal. 2025 Feb;45(2):457-472. doi: 10.1111/risa.17451. Epub 2024 Aug 16.
5
Evaluating scientific confidence in the concordance of in vitro and in vivo protective points of departure.评估体外和体内保护起点一致性的科学置信度。
Regul Toxicol Pharmacol. 2024 Mar;148:105596. doi: 10.1016/j.yrtph.2024.105596. Epub 2024 Mar 4.
6
Advancing probabilistic risk assessment by integrating human biomonitoring, new approach methods, and Bayesian modeling: A case study with the mycotoxin deoxynivalenol.通过整合人体生物监测、新方法和贝叶斯建模来推进概率风险评估：以真菌毒素脱氧雪腐镰刀菌烯醇为例的研究。
Environ Int. 2023 Dec;182:108326. doi: 10.1016/j.envint.2023.108326. Epub 2023 Nov 15.
7
Reanalysis of Trichloroethylene and Tetrachloroethylene Metabolism to Glutathione Conjugates Using Human, Rat, and Mouse Liver Models to Improve Precision in Risk Characterization.使用人、大鼠和小鼠肝模型重新分析三氯乙烯和四氯乙烯代谢为谷胱甘肽缀合物，以提高风险特征描述的准确性。
Environ Health Perspect. 2022 Nov;130(11):117009. doi: 10.1289/EHP12006. Epub 2022 Nov 29.
8
Cumulative Risk Meets Inter-Individual Variability: Probabilistic Concentration Addition of Complex Mixture Exposures in a Population-Based Human In Vitro Model.累积风险与个体间变异性相遇：基于人群的人体体外模型中复杂混合物暴露的概率浓度相加
Toxics. 2022 Sep 20;10(10):549. doi: 10.3390/toxics10100549.
9
A Population-Based Human In Vitro Approach to Quantify Inter-Individual Variability in Responses to Chemical Mixtures.一种基于人群的体外方法，用于量化个体对化学混合物反应的个体间变异性。
Toxics. 2022 Aug 1;10(8):441. doi: 10.3390/toxics10080441.
10
Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow.非动物系统性安全评估是否具有保护作用？工具包和工作流程。
Toxicol Sci. 2022 Aug 25;189(1):124-147. doi: 10.1093/toxsci/kfac068.
本文引用的文献
1
The Future of Uncertainty Factors With In Vitro Studies Using Human Cells.人类细胞体外研究中不确定性因素的未来。
Toxicol Sci. 2022 Feb 28;186(1):12-17. doi: 10.1093/toxsci/kfab134.
2
The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.IARC 专著：癌症危险识别中现代透明证据综合的更新程序。
J Natl Cancer Inst. 2020 Jan 1;112(1):30-37. doi: 10.1093/jnci/djz169.
3
Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes.基于人群的毒性筛选在人诱导多能干细胞衍生的心肌细胞中。
Toxicol Appl Pharmacol. 2019 Oct 15;381:114711. doi: 10.1016/j.taap.2019.114711. Epub 2019 Aug 16.
4
Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships.在体 QT/QTc 研究：准确预测临床浓度-QTc 关系的体外人类模型。
Clin Pharmacol Ther. 2019 May;105(5):1175-1186. doi: 10.1002/cpt.1259. Epub 2018 Dec 2.
5
A tiered, Bayesian approach to estimating of population variability for regulatory decision-making.一种用于监管决策的分层贝叶斯方法来估计群体变异性。
ALTEX. 2017;34(3):377-388. doi: 10.14573/altex.1608251. Epub 2016 Dec 13.
6
Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study.基于人群的化学物质体外危害和浓度-反应评估：千人基因组高通量筛选研究
Environ Health Perspect. 2015 May;123(5):458-66. doi: 10.1289/ehp.1408775. Epub 2015 Jan 13.
Zotero 插件